Skip to content

Multidimensional Analysis of Chlamydia Test Uptake in Women Aged 16 to 25

Multidimensional Analysis of Chlamydia Test Uptake in Women Aged 16 to 25 - FemScreen-CT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039884
Enrollment
12617
Registered
2026-06-03
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Chlamydia trachomatis (CT) infections in asymptomatic women aged 15–25 years

Interventions

Group 1: WP1: WP1.1 Anonymous, asynchronous, chat-app-based online focus group. WP1.2: Quantitative cross-sectional survey study (online) of sexually active women aged 16 to 25 years. WP1.3: Analysis

Sponsors

Universitätsklinikum Bonn (AöR)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 25 Years

Inclusion criteria

Inclusion criteria: AP1.1: A smartphone, tablet, or computer with internet access is required. AP1.2: Memberhsip in one of the three cooperating health insurance funds. Additional criteria: • A: Women aged 16–25 with consultation code GOP 01821 and GOP 01822 • B: Women aged 16–25 with consultation code GOP 01821 or GOP 01822 and GOP 01823 (supplement to GOP 01821 and GOP 01822 for counselling on CT screening) • C: Women aged 16–25 with consultation code GOP 01821 or GOP 01822 and GOP 01840 and GOP 01824 (initiation of urine sample analysis for Chlamydia trachomatis, result negative (no chlamydia diagnosis according to ICD-10: A56.-)) • D: Women aged 16–25 with a positive chlamydia test according to ICD-10, A56.- (chlamydial diseases transmitted by sexual intercourse) AP1.3: Women from selection group D. AP3: Only physicians working in a gynaecological practice are included.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Identification of facilitators and barriers to the uptake of the statutory chlamydia screening programme for asymptomatic women aged 16 to 25 years in Germany (WP1–WP4), as well as the development of consensual recommendations for action with relevant stakeholders (WP5). Due to the exploratory design, no hypotheses are formulated in advance.

Countries

Germany

Contacts

Public ContactNadine Scholten

Center for Health Services Research and Communication (CHSR) ,Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Bonn AöR

nadine.scholten@ukbonn.de+49 228 28752500

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026